Allentown, Pennsylvania (PRWEB) February 26, 2013
The recent blizzard in the Northeast notwithstanding, many areas of the U.S. have experienced a mild winter, with unseasonably warm weather. A mild winter can signify an early allergy season, since trees tend to start pollinating earlier.(1)
People with COPD, asthma, emphysema, bronchitis, cystic fibrosis, and lung transplants are using the Spiro PD Personal Spirometer to monitor their lung health and to get “baseline” readings to compare with peak allergy season.
Spiro PD the is the world’s first personal spirometer. It empowers people with respiratory conditions to easily and accurately monitor their breathing any time and anywhere: at home, work, school, play, or while traveling. Spiro PD also helps patients anticipate and prevent respiratory disease exacerbations, which may reduce expensive emergency room visits and hospital stays.
According to a Johns Hopkins University study, home spirometry detected a decline in lung function 16 days before patients felt symptoms and sought medical care.(2) Spiro PD’s ability to note early detection of decreased lung function can catch problems before they worsen and prevent unnecessary hospitalization of chronic respiratory patients.
Spiro PD lets patients quickly and simply upload their lung health data and share it with their doctor. So, if necessary, the doctor can easily make changes to the patient’s treatment in a timely manner.
Spiro PD enhances medication adherence by letting patients set alarms reminding them when to take their medicine, plus when to test their lung function and do breathing exercises.
Wayne Meng, Founder, Chief Executive Officer, and President of PMD Healthcare, the maker of Spiro PD, says, “Allergy season is just around the corner. Spiro PD empowers patients to take steps now to help prevent exacerbations or complications resulting from their respiratory condition.”
About Spiro PD
“Spiro" stands for spirometer, a device used to measure air entering and leaving the lungs; "PD" stands for personal device. Spiro PD is the first personal spirometer that enables people with lung diseases – COPD, asthma, CF, and lung transplants – to easily and accurately monitor their breathing anytime and anywhere.
Spiro PD tracks lung function trends to help patients anticipate and prevent respiratory disease exacerbations, which helps reduce expensive emergency room visits and hospital stays. According to a study conducted at Johns Hopkins University, home spirometry detected decreased lung function 16 days before patients felt symptoms and sought medical care.(2)
Spiro PD enhances medication adherence. The medication alarm helps patients remember to take their medicine. The medication history provides a time stamp to show doctors that patients have been following their therapy.
Spiro PD also allows patients to set alarms reminding them to perform spirometry tests and do breathing exercises. Plus, patients can quickly upload data to their computer and share it with their doctor.
Spiro PD is cleared by the FDA for home use by the patient to test lung function in children, adolescents, and adults. Many insurance companies cover the cost of Spiro PD. Spiro PD meets American Thoracic Society (ATS) and European Respiratory Society (ERS) standards. Spiro PD is also certified with the CE mark for the European Union (EU).
For more information, visit http://www.SpiroPD.com.
About PMD Healthcare, Inc.
PMD Healthcare, manufacturer of Spiro PD, is dedicated to creating innovative, easy-to-use, portable, and affordable personal medical devices that empower people worldwide to improve their healthcare and quality of life. For more information about PMD Healthcare and Spiro PD, please visit http://www.SpiroPD.com.
1. Pollen.com. How Weather Affects Allergy Forecasts. http://www.pollen.com/allergy-season.asp. Retrieved 2013-2-13.
2. CDC Questions and Answers 2010-01-27. Retrieved 2010-08-10.